V. de Ruiter

An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity

M. Dorywalska, K. Ching, L. Mosyak, 2021, Cancer Immunology Research.

Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

U. Şahin, M. Bruno, P. Boor, 2022, Oncoimmunology.

Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells

Jyaysi Desai, P. Boor, J. Kwekkeboom, 2022, British Journal of Cancer.

GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells

J. Kwekkeboom, J. Ijzermans, M. Vermaas, 2022, Cellular and molecular gastroenterology and hepatology.

Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex-vivo targeting immune checkpoint molecules.

J. Ijzermans, M. Bruno, S. Mancham, 2019, Journal of hepatology.

FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells

K. Ching, S. Salek-Ardakani, J. Ijzermans, 2020, Journal for ImmunoTherapy of Cancer.